Development of an immunohistochemistry assay for PD-L1 for using the 22C3 antibody in melanoma.
2016
e14503Background: The expression of PD-L1 has been reported in a number of human malignancies. Studies showed the correlation of PD-L1 expression in tumor or inflammatory cells, with clinical outco...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI